Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Body posture and salbutamol reversibility in children with asthma
NL-OMON22687Not yet recruiting
- Sponsor
- Medisch Spectrum Twente
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of salbutamol in asthma (2 arms), sponsored by Medisch Spectrum Twente. Primary endpoints: FEV1 reversibility, VC reversibility and 3 more. Planned start Jan 2014; status: not yet recruiting.
02
Drugs
salbutamol
03
Conditions
asthma
Beyond the preview
Go deeper on NL-OMON22687.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON22687.